Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled Phase 2b Dry Eye Disease Clinical Trial to Evaluate Safety and Efficacy of Topical Ocular Reproxalap, a Novel RASP Inhibitor Meeting Abstract

publication date

  • July 1, 2019

webpage

published in

volume

  • 60

issue

  • 9